Wordt geladen...
Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
CPT-11 (irinotecan), a DNA topoisomerase I inhibitor is one of the main treatments for colorectal cancer. The main dose limiting toxicities are neutropenia and late onset diarrhea. Though neutropenia is manageable, CPT-11 induced diarrhea is frequently severe, resulting in hospitalizations, dose red...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4004171/ https://ncbi.nlm.nih.gov/pubmed/23597015 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|